Skip to main content

Table 5 Multivariate analysis of TB Treatment outcome with socio-demographic and Clinical characteristics of TB/HIV co-infected patients attended Public hospitals of Harar town, Eastern Ethiopia, 2018

From: Treatment Outcome of Tuberculosis and Associated Factors among TB-HIV Co-Infected Patients at Public Hospitals of Harar Town, Eastern Ethiopia. A five-year retrospective study

Characteristics

Treatment outcome

P- value

Adjusted Odds Ratio (AOR) (95% CI)

Successful Treatment

Unsuccessful treatment

Pretreatment Weight

 20–29 Kg

4 (80.0%)

1 (20.0%)

0. 843

0.92 (0.38–2.19)

 30–39 Kg

16 (72.7%)

6 (27.3%)

0.244

0.22 (0.02–2.79)

 40–54 Kg

135 (86.5%)

21 (13.5%)

0.150

0.40 (0.12–1.39)

  > 54 Kg

148 (89.2%)

18 (10.8%)

 

1.00

Pretreatment BMI (kg/m2)

  < 18.5

81 (82.7%)

17 (17.3%)

 

1.00

 18.5–24.9

176 (87.6%)

25 (12.4%)

0.834

0.85 (0.18–4.01)

  ≥ 25

46 (92.0%)

4 (8.0%)

0.497

0.64 (0.17–2.34)

Patient category

 New cases

273 (88.1%)

37 (11.9%)

0.022

1.00

 Re treatment

30 (76.9%)

9 (23.1%)

2.91 (1.17–7.28)

Types of TB

 SPP TB

90 (81.1%)

21 (18.9%)

 

1.00

 EP TB

102 (85.7%)

17 (14.3%)

0.003

0.23 (0.09–0.62)

 SNP TB

111 (93.3%)

8 (6.7%)

0.032

0.34 (0.13–0.91)

WHO staging

 stage 1

72 (91.1%)

7 (8.9%)

 

1.00

 stage 2

94 (92.2%)

8 (7.8%)

0.022

4.46 (1.24–16.02)

 stage 3

109 (85.2%)

19 (14.8%)

0.003

5.94 (1.87–18.85)

 stage 4

28 (70.0%)

12 (30.0%)

0.025

3.01 (1.15–7.91)

History of opportunistic infection

 No

149 (93.7%)

10 (6.3%)

0.002

1.00

 Yes

154 (81.1%)

36 (18.9%)

3.68 (1.62–8.33)

CPT initiated

 Yes

264 (89.2%)

32 (10.8%)

0.002

1.00

 No

39 (73.6%)

14 (26.4%)

3.54 (1.59–7.89)

CD4 count

  < 200 cells/μL

83 (81.4%)

19 (18.6%)

 

1.00

 201–499 cells/μL

155 (90.1%)

17 (9.9%)

0.451

1.50 (0.52–4.33)

 ≥ 500 cells/μL

65 (86.7%)

10 (13.3%)

0.433

1.47 (0.56–3.82)

  1. Significant values are set in bold